NCT00243217View on ClinicalTrials.gov

Rotigotine Restless Legs Syndrome Dose Finding Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

341

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Idiopathic Restless Leg Syndrome
Interventions
DRUG

SPM 936

Trial Locations (1)

Unknown

Schwarz, Monheim

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00243217 - Rotigotine Restless Legs Syndrome Dose Finding Trial | Biotech Hunter | Biotech Hunter